BSME — MED EIBY Holding Co Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for MED EIBY Holding Co, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 3.67 | 2.78 | 3.39 |
| Cost of Revenue | |||
| Gross Profit | 0.981 | 0.571 | 0.789 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Total Operating Expenses | 4.45 | 3.98 | 5.5 |
| Operating Profit | -0.786 | -1.21 | -2.11 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.79 | -1.51 | -2.15 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.827 | -1.34 | -2.33 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.827 | -1.34 | -2.33 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.827 | -1.34 | -2.33 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.05 | -0.08 | -0.139 |
| Dividends per Share |